Associate Director, Corneal and External Disease Service
Refractive Surgery Service
Background
Terry Kim, MD, received his undergraduate
and medical school degrees from Duke University and completed his residency and
chief residency in ophthalmology at Emory University. He continued with his fellowship training in
Cornea and External Disease and Refractive Surgery at Wills Eye Hospital. He was then recruited to Duke Eye
Center, where he is a full-time faculty member of the Corneal and Refractive
Surgery Services. Dr. Kim serves as principal investigator on a major research
grant from the National Institutes of
Health to investigate innovative corneal adhesives and wound healing. He was
formerly the Director of the Residency Program and now serves as the Director
of Fellowship Programs.
Dr. Kim's academic accomplishments include his extensive publications in
the peer-reviewed literature, which include close to 100 journal articles and
textbook chapters. He is also
co-author and co-editor of 2 well-respected textbooks on corneal diseases and
cataract surgery.
Dr. Kim has delivered well over 200
invited lectures both nationally and internationally. His
clinical and research work has earned him honors and grants from the American Academy of Ophthalmology (AAO), American
Society of Cataract and Refractive Surgery (ASCRS), National Institutes
of Health, Fight for
Sight/Research to Prevent Blindness,
Heed Ophthalmic Foundation, Alcon Laboratories, and Allergan. He is also listed in Best Doctors
in America, Best
Doctors in North Carolina, and America's
Top Ophthalmologists.
Dr. Kim is on the Annual Program
Committee for the AAO and on the Cornea Clinical Committee for the ASCRS. He serves as consultant to the Ophthalmic
Devices Panel of the FDA and sits on the Editorial Board for the journals Cornea,
Ocular Surgery News, Eyeworld, Cataract & Refractive Surgery Today, and Review of Ophthalmology. As Consultant Ophthalmologist for
the Duke Men's Basketball Team, Dr. Kim provides ophthalmic care for the
players and coaches and has performed surgical procedures which have been
featured on nationally televised programs like the Discovery Channel.
Research Interests
Kim's clinical and basic science research areas focus on two projects, both
of which receive NIH/NEI funding. The first project involves the potential
clinical applications of new corneal adhesives known as biodendrimers. These
new and unique molecules are developed and synthesized by Dr. Mark Grinstaff of
the Chemistry Department at Boston
University. They are then
tested in in-vitro (human eyebank eyes) and in-vivo (chicken eyes) settings to
study adhesive behavior and effectiveness. Some biodendrimers have already been
tested and found to have many advantages over traditional cyanoacrylate
adhesives as well as conventional sutures. Hopefully, these new biodendrimers
will offer a new approach to the repair of corneal wounds, including clear corneal
cataract incisions, corneal lacerations, LASIK flaps, and corneal transplants.
The second focus involves investigating potential anterior
segment applications of spectral-domain optical coherence tomography (OCT)
imaging, a new modification developed by Dr. Joseph Izatt of Duke's Pratt
School of Engineering. Specifically, Kim has used this new real-time technology
to examine LASIK flaps as well as changes that occur in the eye during
accommodation. He is also applying this new imaging technology to examine
corneal wound morphology after cataract surgery as well as tube shunt movement
in the anterior chamber.